Tourmaline Bio Inc. (TRML)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$47.98

+0.00 (+0.00%)

Market Cap: $1.23B

Last updated: Oct 14, 2026 at 5:00 PM ET

Earnings

Performance (10Y)

Beat Rate

39%(7/18)

Avg Surprise

-571.53%

Streak

6 Q

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2025Jun 25 Reported Aug 13, 2025Reported Aug 13	$-0.90	$-0.91	$-1.05 - $-0.78	+1.10%	Beat	8	2 3 30d	-32.4%
Mar 31, 2025Mar 25 Reported May 2, 2025Reported May 2	$-0.89	$-0.94	$-1.04 - $-0.80	+4.95%	Beat	8	0 3 30d	-61.8%
Dec 31, 2024Dec 24 Reported Mar 13, 2025Reported Mar 13	$-0.86	$-0.87	$-1.13 - $-0.72	+1.15%	Beat	8	0 3 30d	-6.2%
Sep 30, 2024Sep 24 Reported Nov 7, 2024Reported Nov 7	$-0.78	$-0.82	$-0.97 - $-0.72	+4.88%	Beat	7	No revisions (30d)	+52.5%
Jun 30, 2024Jun 24 Reported Aug 8, 2024Reported Aug 8	$-0.68	$-0.71	-	+4.23%	Beat	-	-	+80.5%
Mar 31, 2024Mar 24 Reported May 13, 2024Reported May 13	$-0.55	$-0.67	-	+17.91%	Beat	-	-	-48.6%
Dec 31, 2023Dec 23 Reported Mar 19, 2024Reported Mar 19	$-0.81	$-0.79	-	-2.53%	Miss	4	No revisions (30d)	+84.4%
Sep 30, 2023Sep 23 Reported Nov 14, 2023Reported Nov 14	$-1.64	$-0.60	$-0.60 - $-0.60	-173.68%	Miss	1	No revisions (30d)	+64.3%
Jun 30, 2023Jun 23 Reported Aug 14, 2023Reported Aug 14	$-3.49	$-0.20	$-0.20 - $-0.20	-1647.35%	Miss	0	No revisions (30d)	+20.6%
Mar 31, 2023Mar 23 Reported May 11, 2023Reported May 11	$-0.37	$-0.46	-	+18.68%	Beat	-	-	+91.8%
Dec 31, 2022Dec 22 Reported Mar 30, 2023Reported Mar 30	$-5.20	$-0.49	-	-961.22%	Miss	-	-	-48.6%
Sep 30, 2022Sep 22 Reported Nov 10, 2022Reported Nov 10	$-4.60	$-0.45	-	-913.22%	Miss	-	-	-43.7%
Jun 30, 2022Jun 22 Reported Aug 15, 2022Reported Aug 15	$-4.40	$-0.46	-	-867.03%	Miss	-	-	-7.3%
Mar 31, 2022Mar 22 Reported Jun 29, 2022Reported Jun 29	$-4.50	$-0.38	-	-1074.02%	Miss	-	-	+65.4%
Dec 31, 2021Dec 21 Reported Mar 30, 2022Reported Mar 30	$-3.50	$-0.38	-	-829.12%	Miss	-	-	-2087.5%
Sep 30, 2021Sep 21 Reported Dec 29, 2021Reported Dec 29	$-3.20	$-0.35	-	-814.29%	Miss	-	-	-
Jun 30, 2021Jun 21 Reported Sep 28, 2021Reported Sep 28	$-4.10	$-0.26	-	-1476.92%	Miss	-	-	-
Mar 31, 2021Mar 21 Reported Jun 29, 2021Reported Jun 29	$-13.00	$-0.77	-	-1581.11%	Miss	-	-	-
Dec 31, 2020Dec 20 Reported Mar 30, 2021Reported Mar 30	$-0.16	$0.00	-	N/A	Miss	-	-	-

Dividends

Dividend Metrics

Forward Yield0.00%

Forward Annual Dividend$0.00

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-29.60%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	N/A
Current Ratio	24.68x	Quick Ratio	24.68x
Trading Statistics
Beta	1.58	Avg Volume	N/A
52-Week High	$48.00	52-Week Low	$47.88

Technical Indicators Dashboard

Moving Averages

SMA 10$47.98

SMA 20$47.98

SMA 50$47.98

SMA 200$47.96

EMA 10$47.98

EMA 20$47.98

EMA 50$47.97

EMA 200$44.06

MACD

Line: N/ASignal: N/AHist: N/A

ADX

ADX: 84.1+DI: 58.9-DI: 5.1

Aroon & PSAR

Aroon Up100.0

Aroon Down100.0

PSAR$47.97

Bollinger Bands

Upper Band$47.98

Lower Band$47.98

%B PositionN/A

Band Width-32.00

RSI (14-Day)

Overbought

89.4

Momentum Oscillators

Stoch %KN/A

Stoch %DN/A

Williams %RN/A

ROC (10d)N/A

MomentumN/A

CCI (20d)N/A

MFI (14d)N/A

Volatility Measures

ATR (14d)N/A

StdDev (20d)N/A

Hist VolN/A

Volume Flow

VWAP$47.98

OBV31.1M

AD Line3.9M

CMF (20d)N/A

Volume Metrics

Avg Vol (20d)N/A

Vol RatioN/A

VWMA (20d)N/A

Pivot Points

R3$47.98

R2$47.98

R1$47.98

Pivot Point$47.98

S1$47.98

S2$47.98

S3$47.98

Advanced Oscillators

TSI78.37

Ultimate OscN/A

KSTN/A

Financial Data

Quarter	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Total Revenue	$0	$0	$40,000	$0	$0	$0	$2.28M	$0	$0	$0	$0	$0
Cost of Revenue	$0	$0	$20,000	$0	$0	$0	$1.14M	$0	$0	$0	$553,000	$0
Gross Profit	$0	$0	$20,000	$0	$0	$0	$1.14M	$0	$0	$0	$-553,000	$0

Operating Expenses	$25.97M	$26.23M	$25.81M	$24.44M	$21.97M	$17.52M	$14.89M	$6.64M	$16.37M	$7.50M	$-36,951,000	$19.82M
R&D	$19.63M	$20.26M	$20.55M	$19.33M	$15.73M	$11.38M	$8.02M	$3.76M	$14.45M	$6.14M	$-24,838,000	$14.98M
SG&A	$6.34M	$5.97M	$5.26M	$5.11M	$6.24M	$6.14M	$6.88M	$2.88M	$1.92M	$1.36M	$-12,113,000	$4.84M
Operating Income	$-25,974,000	$-26,231,000	$-25,806,000	$-24,438,000	$-21,971,000	$-17,517,000	$-14,890,000	$-6,643,000	$-16,374,000	$-7,502,000	$36.95M	$-19,823,000

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$812,000
Interest Expense	$0	$0	$12.95M	$0	$0	$0	$245,000	$0	$0	$0	$1.21M	$0
Income Before Tax	$-25,974,000	$-26,231,000	$-38,757,000	$-20,177,000	$-21,971,000	$-13,311,000	$-15,135,000	$-6,643,000	$-16,129,000	$-7,502,000	$35.74M	$-19,090,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-23,092,000	$-22,970,000	$-22,235,000	$-20,177,000	$-17,487,000	$-13,311,000	$-12,902,000	$-5,591,000	$-16,129,000	$-7,502,000	$35.66M	$-19,011,000

EBITDA	$-27,397,000	$-27,781,000	$-27,769,000	$-22,318,000	$-24,251,000	$-14,482,000	$-15,401,000	$-6,695,000	$-16,093,000	$-7,464,000	$35.97M	$-19,861,000
EBIT	$-25,974,000	$-26,231,000	$-25,806,000	$-20,177,000	$-21,971,000	$-13,311,000	$-14,890,000	$-6,643,000	$-16,129,000	$-7,502,000	$36.95M	$-19,902,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about TRML

News

No news available

Company news will appear here when available

TRML Valuation and Fair Value

P/B: 4.8x

See GNG's fair value

TRML Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROE: -29.6%

TRML Competitors

Company	Ticker
InnovAge Holding Corp	INNV
Oric Pharmaceuticals Inc	ORIC
Syndax Pharmaceuticals Inc	SNDX
CareCloud, Inc.	CCLDO
Inhibrx Biosciences, Inc.	INBX
Cronos Group Inc	CRON
Nektar Therapeutics	NKTR
Goodrx Holdings Inc	GDRX

Sector: Healthcare

TRML Bull Case vs Bear Case

Bull case

TRML beat EPS estimates in 75.0% of its last 8 reported quarters.

TRML Earnings: Beat Rate and Next Report

Beat rate: 6 of 8 quarters (75.0%)
Average surprise: -17.8%

TRML Dividend

Forward yield: 0.0%

Frequently Asked Questions About TRML

Does TRML pay dividends?

Tourmaline Bio Inc. (TRML) has a dividend payment track record. See the TRML dividend history page for its current payment status, TTM yield, and recorded payments.

What is TRML's market cap?

Tourmaline Bio Inc. (TRML) has a market capitalization of $1.23B with a current stock price of $47.98.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In